Ben Hackett

First Year of Call
Ontario

Areas of Practice
Commercial Litigation

Description
Ben Hackett is a partner in the Litigation and Dispute Resolution Group at Goodmans. He practices commercial litigation, with an emphasis on intellectual property litigation. Ben has been counsel on a number of significant cases involving patent validity and infringement, damages and profits quantification and recovery under section 8 of the Patented Medicines (NOC) Regulations on behalf of generic clients. He has also acted on a number of judicial reviews and damages claims against the Federal government. Additionally, Ben has acted as counsel on actions before the Federal Court seeking recovery under the Competition Act. He appears regularly at the trial and appeal levels of the Federal Courts and has appeared before the Supreme Court of Canada.

Chambers Canada 2026 ranks Ben in Band 3, with peers describing him as “an outstanding young IP litigator, an excellent oral advocate and cross-examiner.” He “holds a solid reputation as an IP litigator and has played an important role in several high-profile patent litigation cases, particularly in the pharmaceutical sector.” Ben is also recognized as a leading lawyer in the Lexpert Special Edition: Technology, the Lexpert Special Edition: Health Sciences, and the Lexpert Special Edition: Litigation since 2018. He is ranked “Silver” by IAM Patent 1000 and is described as “the best young partner in the Canadian patent scene.” The Canadian Legal Lexpert Directory “Consistently Recommends” Ben for litigation – intellectual property and “Repeatedly Recommends” him for intellectual property and life sciences & health. He is recognized as a leading intellectual property lawyer by Best Lawyers in Canada since 2015 and he is recognized as a “Litigation Star” for intellectual property litigation by Benchmark Canada. Ben is recognized by The Legal 500 Canada as a “Next Generation Partner” and IP Stars as a “Patent Star.” He is also recognized as a leading patent litigator by Lexology Index: Life Sciences – Patent Litigation 2021 and IP – Patents 2021.